Helen Schmid

2.5k total citations
39 papers, 794 citations indexed

About

Helen Schmid is a scholar working on Oncology, Dermatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Helen Schmid has authored 39 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 11 papers in Dermatology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Helen Schmid's work include Cutaneous Melanoma Detection and Management (18 papers), Skin Protection and Aging (10 papers) and Allergic Rhinitis and Sensitization (5 papers). Helen Schmid is often cited by papers focused on Cutaneous Melanoma Detection and Management (18 papers), Skin Protection and Aging (10 papers) and Allergic Rhinitis and Sensitization (5 papers). Helen Schmid collaborates with scholars based in Australia, United States and United Kingdom. Helen Schmid's co-authors include Graham J. Mann, Rolf Nöthiger, Richard Kefford, Monica Steinmann‐Zwicky, Anne Ε. Cust, Graham G. Giles, Mark A. Jenkins, John L. Hopper, Joanne F. Aitken and Bruce K. Armstrong and has published in prestigious journals such as Cell, American Journal of Epidemiology and The Journal of Urology.

In The Last Decade

Helen Schmid

36 papers receiving 780 citations

Peers

Helen Schmid
Catherine Quigley United States
Nge Cheong Singapore
J Yodoi Japan
John F. Dunne United States
Mijke Visser Netherlands
David Petersen United States
G.P. Holmquist United States
Catherine Quigley United States
Helen Schmid
Citations per year, relative to Helen Schmid Helen Schmid (= 1×) peers Catherine Quigley

Countries citing papers authored by Helen Schmid

Since Specialization
Citations

This map shows the geographic impact of Helen Schmid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Schmid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Schmid more than expected).

Fields of papers citing papers by Helen Schmid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Schmid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Schmid. The network helps show where Helen Schmid may publish in the future.

Co-authorship network of co-authors of Helen Schmid

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Schmid. A scholar is included among the top collaborators of Helen Schmid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Schmid. Helen Schmid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Andrea L., Serigne Lo, Nadine A. Kasparian, et al.. (2024). Short‐Term Effectiveness of a Stepped‐Care Model to Address Fear of Cancer Recurrence in Patients With Early‐Stage Melanoma. Psycho-Oncology. 33(12). e70041–e70041.
2.
Ebner, R., AW Lohse, Matthias P. Fabritius, et al.. (2024). Validation of the standardization framework SSTR-RADS 1.0 for neuroendocrine tumors using the novel SSTR‑targeting peptide [18F]SiTATE. European Radiology. 34(11). 7222–7232. 3 indexed citations
3.
Smith, Andrea L., Serigne Lo, Nadine A. Kasparian, et al.. (2022). Protocol for the implementation of a stepped-care model to address fear of cancer recurrence in patients previously diagnosed with early-stage (0–II) melanoma. BMJ Open. 12(3). e054337–e054337. 4 indexed citations
4.
Holland, Elizabeth A., Serigne Lo, Helen Schmid, et al.. (2020). FRAMe: Familial Risk Assessment of Melanoma—a risk prediction tool to guide CDKN2A germline mutation testing in Australian familial melanoma. Familial Cancer. 20(3). 231–239. 5 indexed citations
5.
Smith, Andrea L., Caroline G. Watts, Samuel Robinson, et al.. (2020). Knowledge and attitudes of Australian dermatologists towards sentinel lymph node biopsy for melanoma: a mixed methods study. Australasian Journal of Dermatology. 62(2). 168–176. 3 indexed citations
6.
Smith, Andrea L., Caroline G. Watts, Samuel Robinson, et al.. (2020). GPs’ involvement in diagnosing, treating, and referring patients with suspected or confirmed primary cutaneous melanoma: a qualitative study. BJGP Open. 4(2). bjgpopen20X101028–bjgpopen20X101028. 16 indexed citations
7.
Armstrong, Bruce K., Martin Drummond, John L. Hopper, et al.. (2019). Development and external validation study of a melanoma risk prediction model incorporating clinically assessed naevi and solar lentigines. British Journal of Dermatology. 182(5). 1262–1268. 13 indexed citations
8.
Cust, Anne Ε., Kristen Pickles, Chris Goumas, et al.. (2015). Accuracy of Self-Reported Nevus and Pigmentation Phenotype Compared with Clinical Assessment in a Population-Based Study of Young Australian Adults. Cancer Epidemiology Biomarkers & Prevention. 24(4). 736–743. 12 indexed citations
9.
Cust, Anne Ε., Mark A. Jenkins, Chris Goumas, et al.. (2011). Early-life sun exposure and risk of melanoma before age 40 years. Cancer Causes & Control. 22(6). 885–897. 33 indexed citations
10.
Cust, Anne Ε., Chris Goumas, Elizabeth A. Holland, et al.. (2011). MC1R genotypes and risk of melanoma before age 40 years: A population‐based case‐control‐family study. International Journal of Cancer. 131(3). E269–81. 19 indexed citations
11.
Cust, Anne Ε., Bruce K. Armstrong, Chris Goumas, et al.. (2010). Sunbed use during adolescence and early adulthood is associated with increased risk of early-onset melanoma. Pigment Cell & Melanoma Research. 23(6). 923. 4 indexed citations
12.
Cust, Anne Ε., Bruce K. Armstrong, Chris Goumas, et al.. (2010). Sunbed use during adolescence and early adulthood is associated with increased risk of early‐onset melanoma. International Journal of Cancer. 128(10). 2425–2435. 154 indexed citations
13.
Cust, Anne Ε., Helen Schmid, Jodie Jetann, et al.. (2009). Population-based, Case-Control-Family Design to Investigate Genetic and Environmental Influences on Melanoma Risk: Australian Melanoma Family Study. American Journal of Epidemiology. 170(12). 1541–1554. 35 indexed citations
14.
Prikler, Ladislav, Elke Scandella, Yi Men, et al.. (2004). Adaptive Immuntherapie des fortgeschrittenen Prostatakarzinoms - Cancer Testis Antigene (CTA) als mögliche Zielantigene. Aktuelle Urologie. 35(4). 326–330. 7 indexed citations
15.
Schmid, Helen, et al.. (2000). Neoadjuvant Hormonal Therapy in Radical Prostatectomy and Radiation-Treated Patients. Urologia Internationalis. 65(2). 63–67. 1 indexed citations
16.
Eble, Michael J., D. Wallwiener, H. Junkermann, et al.. (1997). Tumor Debulking and IORT for Recurrent Gynecological Carcinomas of the Pelvic Sidewall. Frontiers of radiation therapy and oncology. 31. 263–266. 2 indexed citations
17.
Stamey, T A, et al.. (1995). In Reply: Re The Value of Serial Prostate Specific Antigen Determinations 5 Years After Radiotherapy. The Journal of Urology. 153(6). 1954–1954. 8 indexed citations
18.
Hering, F., Helen Schmid, & Peter Gräber. (1994). Influence of microinvasion of the capsule and/or micrometastasis of regional lymph nodes on disease free survival after radical prostatectomy.. PubMed. 28(4). 196–201. 2 indexed citations
19.
Steinmann‐Zwicky, Monica, Helen Schmid, & Rolf Nöthiger. (1989). Cell-autonomous and inductive signals can determine the sex of the germ line of Drosophila by regulating the gene Sxl. Cell. 57(1). 157–166. 127 indexed citations
20.
Schmid, Helen. (1972). Schistosome Ova Deposits in the Appendix. Pathobiology. 38(5). 362–374. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026